Meitav Dash Investments LTD Uro Gen Pharma Ltd. Transaction History

Meitav Dash Investments LTD

$5.8 Billion
Q3 2024

A detailed history of Meitav Dash Investments LTD transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Meitav Dash Investments LTD holds 36,138 shares of URGN stock, worth $413,780. This represents 0.01% of its overall portfolio holdings.

Number of Shares

36,138

Previous 36,798 1.79%

Holding current value

$413,780

Previous $617,000 25.77%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$12.7 - $17.92 $8,382 - $11,827	-660 Reduced 1.79%	36,138 $458,000
Q1 2024 May 01, 2024	SELL	$13.81 - $19.33 $754,826 - $1.06 Million	-54,658 Reduced 59.76%	36,798 $551,000
Q3 2023 Oct 30, 2023	SELL	$8.84 - $22.64 $124,255 - $318,227	-14,056 Reduced 13.32%	91,456 $1.28 Million
Q2 2023 Jul 24, 2023	SELL	$8.75 - $14.29 $14,875 - $24,293	-1,700 Reduced 1.59%	105,512 $1.09 Million
Q1 2023 May 11, 2023	SELL	$7.99 - $11.02 $236,687 - $326,445	-29,623 Reduced 21.65%	107,212 $990,000
Q1 2022 May 09, 2022	SELL	$5.92 - $9.73 $114,557 - $188,285	-19,351 Reduced 12.39%	136,835 $1.19 Million
Q4 2021 Feb 08, 2022	BUY	$9.03 - $19.13 $267,251 - $566,171	29,596 Added 23.38%	156,186 $1.5 Million
Q3 2021 Nov 03, 2021	BUY	$14.31 - $18.39 $373,076 - $479,445	26,071 Added 25.94%	126,590 $2.13 Million
Q2 2021 Aug 05, 2021	BUY	$15.2 - $20.94 $566,032 - $779,784	37,239 Added 58.85%	100,519 $1.54 Million
Q1 2021 May 06, 2021	BUY	$17.99 - $26.96 $1.14 Million - $1.71 Million	63,280 New	63,280 $1.23 Million
Q4 2020 Feb 02, 2021	SELL	$17.54 - $25.43 $849,058 - $1.23 Million	-48,407 Closed	0 $0
Q3 2020 Nov 05, 2020	BUY	$18.81 - $26.42 $96,909 - $136,115	5,152 Added 11.91%	48,407 $934,000
Q2 2020 Aug 10, 2020	BUY	$16.5 - $29.7 $212,008 - $381,615	12,849 Added 42.26%	43,255 $1.13 Million
Q1 2020 May 11, 2020	SELL	$13.68 - $34.6 $3.31 Million - $8.36 Million	-241,657 Reduced 88.82%	30,406 $544,000
Q4 2019 Feb 10, 2020	BUY	$21.11 - $34.86 $495,451 - $818,164	23,470 Added 9.44%	272,063 $9.08 Million
Q3 2019 Nov 14, 2019	SELL	$23.83 - $36.44 $7.55 Million - $11.5 Million	-316,955 Reduced 56.04%	248,593 $6.31 Million
Q2 2019 Aug 14, 2019	SELL	$32.75 - $40.35 $9,825 - $12,105	-300 Reduced 0.05%	565,548 $20.3 Million
Q1 2019 May 13, 2019	BUY	$35.47 - $54.55 $5.23 Million - $8.04 Million	147,358 Added 35.21%	565,848 $20.9 Million
Q4 2018 Feb 13, 2019	SELL	$38.35 - $50.39 $6.35 Million - $8.35 Million	-165,614 Reduced 28.35%	418,490 $18 Million
Q3 2018 Nov 14, 2018	BUY	$41.65 - $51.7 $3.11 Million - $3.86 Million	74,749 Added 14.68%	584,104 $27.8 Million
Q2 2018 Aug 14, 2018	BUY	$48.35 - $65.33 $3 Million - $4.05 Million	62,003 Added 13.86%	509,355 $30 Million
Q1 2018 May 15, 2018	BUY	$38.64 - $57.54 $1.33 Million - $1.98 Million	34,470 Added 8.35%	447,352 $22.2 Million
Q4 2017 Feb 15, 2018	BUY	$27.28 - $43.26 $11.3 Million - $17.9 Million	412,882	412,882 $15.4 Million

Others Institutions Holding URGN

# of Institutions

130

Shares Held

35.9M

Call Options Held

22K

Put Options Held

93.8K

View Full List

About UroGen Pharma Ltd.

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $260M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

More about URGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meitav Dash Investments LTD, based on Form 13F filings with the SEC.

News

Stay updated on Meitav Dash Investments LTD with notifications on news.

Account

Meitav Dash Investments LTD Uro Gen Pharma Ltd. Transaction History